Report #2829840

Received Mar 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Not recovered
Vaccinated: Feb 25, 2025
Onset: Feb 26, 2025
Days to onset: 1
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Pyrexia

Symptom narrative

Fever; This non-serious case was reported by a consumer and described the occurrence of fever in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included arthritis. Concomitant products included methotrexate. On 25-FEB-2025, the patient received Shingrix. On 26-FEB-2025, 1 days after receiving Shingrix, the patient experienced fever (Verbatim: Fever). The outcome of the fever was not resolved. It was unknown if the reporter considered the fever to be related to Shingrix. It was unknown if the company considered the fever to be related to Shingrix. Additional Information: GSK Receipt Date: 26-FEB-2025 The patient self-reported this case for himself. The patient received Shingrix vaccine and experienced fever. The symptoms were treated.

Current illness

Arthritis

Other medications

Methotrexate